CLINICAL TRIAL: ACTG 219: PEDIATRIC LATE OUTCOMES (AIDS)

临床试验：ACTG 219：儿科晚期结果（艾滋病）

• 批准号: 7718380
• 负责人: William Borkowsky
• 金额: $ 0.64万
• 依托单位: NEW YORK UNIVERSITY SCHOOL OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-04-01 至 2009-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7718380
• 关键词: AIDS clinical trial group; Acquired Immunodeficiency Syndrome; Anti-HIV Therapy; Child; Clinical; Clinical Trials; Computer Retrieval of Information on Scientific Projects Database; Data; Disease; Disease Progression; Evaluation; Funding; Grant; HIV; Infant; Institution; Intervention; Laboratories; Morbidity - disease rate; Outcome; Quality-of-Life Assessment; Recording of previous events; Research; Research Personnel; Resources; Source; United States National Institutes of Health; design; follow-up; mortality; neurocognitive test; prophylactic; prospective; treatment effect

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. There is a need to better assess both positive and negative late consequences of the various anti-HIV therapies administered to children. This study is designed to collect prospective, longitudinal data to identify 1)late outcomes and consequences related to HIV disease progression, treatment or prophylactic intervention, and/or interaction of HIV disease and therapy and 2) late treatment effects among perinatally treated infants proven to be uninfected. Data will include history, quality of life assessment, physical exam, neurocognitive testing, clinical and laboratory evaluations, morbidity, and mortality. The study will last until the child reaches his/her 21st birthday or is lost to follow-up.

这个子项目是众多研究子项目之一